Twitter | Search | |
Search Refresh
TRIANGEL RSD LIMITED 7h
980nm vascular removal spider veins treatment with instant effect seen
Reply Retweet Like
Aarren Mannion 13h
Super excited I got funding to attend the autumn 2019 meeting in sunny California! Any tweeps attending?!
Reply Retweet Like
Vascular Biology 2019 4h
Say NO to drugs. To know more about drug effects in heart, visit
Reply Retweet Like
Vascular Biology 2019 Jun 20
Pump in.. Pump out.. the anthem of our heart - WORLD YOGA DAY Visit to know more about challenges faced in cardiovascular system.
Reply Retweet Like
JOBSTUK 2h
The burden of wounds study (Guest et al, 2015) estimated only 16% of patients with a venous had a record of assessment in their patient notes . Read this study
Reply Retweet Like
Vascular Access Centers 18h
The Three Categories of Uterine Fibroids ()
Reply Retweet Like
London North West University Healthcare NHS Trust 20h
Replying to @LNWH_NHS
The minimally invasive treatment means our patients have a short recovery time, and there’s less risk for frail or elderly people. Most of the time, patients will be discharged within a few hours.
Reply Retweet Like
Corindus 18h
. now uses our Corpath GRX System in all of their cath labs. Our CEO Mark Toland also discusses how our is helping to transform and care:
Reply Retweet Like
Porton Health 18h
Postprocedural telemonitoring was hypothesized to reduce surgical site infections and therefore complications of surgery. In the published study, the researchers concluded benefited patient satisfaction more than readmission rates.
Reply Retweet Like
Julie Cardoso Jun 23
C3 Venous Summit 2019 Great content regarding ilio-caval duplex protocol and treatment of venous disease.
Reply Retweet Like
Vascular Access Centers Jun 19
Reply Retweet Like
EhlersDanlos Society 11h
Acer Therapeutics received a Complete Response Letter (CRL) from the U.S. Food and Drug Administration (FDA) for its New Drug Application (NDA) for Edsivo (). Edsivo was being developed for Ehlers-Danlos syndrome ().
Reply Retweet Like
Corindus Jun 24
. recently sat down with our CEO Mark Toland to discuss the importance of their recent system milestone, the capabilities of CorPath GRX, and the future of the industry. Check out the full video here:
Reply Retweet Like
Vascular Access Centers Jun 21
Here are several risk factors that may cause PAD: - Having hypertension (high blood pressure) - Smoking - Diabetes - Obesity, lack of exercise, and high cholesterol. - Being a man over the age of 60, or being a woman after menopause. - Genetics
Reply Retweet Like
Vascular Access Centers Jun 20
Reply Retweet Like
John Chatham Jun 23
Looking forward to the start of Society for and SHVM 2019 in beautiful Arena Hotel In .
Reply Retweet Like
EndothelialCellNews Jun 18
Researchers engineered models of inflammation using a perfusable 3D bed in vitro.
Reply Retweet Like
Acta Neurochirurgica Jun 25
: Ruptured : presentation and treatment outcomes compared to other posterior circulation aneurysms. A SOS study
Reply Retweet Like
Tracey Beck 19h
It’s the grand opening of our new centre today! Great to be joined by the Mayors of Brent, Harrow & Ealing, Cllrs, patients, commissioners, our charity & staff to mark the occasion. Not forgetting the team for bringing it all together!
Reply Retweet Like
Derek Duszynski 5h
Reply Retweet Like